InfraReDx: Near-Infrared Characterization of Coronary Plaque Composition Could Potentially Assist with a Better Understanding of Stent Thrombosis

NEW ORLEANS--(BUSINESS WIRE)--InfraReDx Advisory: What: American College of Cardiology meeting When: March 25 to 27, 2007 Where: New Orleans, LA Why: James Muller, M.D., founder and CEO of InfraReDx (www.infraredx.com), will be available to discuss the manner in which this novel technology could be utilized in clinical trials to address important problems of contemporary cardiology.
MORE ON THIS TOPIC